West nile virus medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(18 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{West nile virus}}
#redirect [[West nile virus infection medical therapy]]
{{CMG}}; {{AE}} {{AL}}
 
==Overview==
There is no specific [[antiviral]] treatment for west nile virus infection.  Current management of these patients is based on supportive care towards [[symptom]] relief and prevention of [[complications]].
 
==Medical Therapy==
====Supportive care  <small><small><small><small>Adapted from CDC<ref name="CDC">{{cite web| url= http://www.cdc.gov/westnile/healthCareProviders/healthCareProviders-TreatmentPrevention.html| title= CDC Treatment and Prevention}}</ref></small></small></small></small>====
* There is no specific [[antiviral]] therapy indicated in patients with west nile virus infection.
* Treatment consist of supportive measurements and prevention of complications.
* In severe cases, patients often need to be hospitalized to receive supportive treatment, such as [[intravenous fluids]], [[analgesics]], and nursing care.
*Patients with severe meningeal symptoms often require pain control for [[headaches]] and antiemetic therapy and rehydration for associated [[nausea]] and [[vomiting]].
*Patients with [[encephalitis]] require close monitoring for the development of elevated [[intracranial pressure]] and [[seizures]].
*Patients with [[encephalitis]] or [[paralysis]] should be monitored for inability to protect their airway.
*Acute neuromuscular [[respiratory failure]] may develop rapidly and prolonged ventilatory support may be required.
*Although various drugs have been evaluated or empirically used for WNV disease, none have shown specific benefit to date.
 
==References==
{{Reflist|2}}

Latest revision as of 17:58, 5 October 2017